FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081478283> ?p ?o ?g. }

• W2081478283 endingPage "654" @default.
• W2081478283 startingPage "649" @default.
• W2081478283 abstract "The most common adverse event typically associated with bisphosphonate therapy is transient fever. The aim of this study was to define the role of the main cytokines of the acute-phase reaction interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) involved in the pathogenesis of zoledronic acid-induced fever. Eighteen consecutive cancer patients with bone metastases were treated, for the first time, with a single dose of 4 mg zoledronic acid infusion. They were prospectively evaluated for circulating TNF-alpha, interferon-gamma (IFN-gamma), and IL-6 levels at different times, just before and 1, 2, 7, and 21 days after diphosphonate infusion. Clinical and standard laboratory parameters were recorded at the same time points. TNF-alpha circulating levels increased significantly 1 and 2 days after zoledronic acid infusion (respectively, p = 0.002 and p < 0.001) and then decreased to levels similar to the basal levels. IL-6 levels increased significantly 1 day after the infusion (p = 0.007), returning to values similar to the median basal values 2 days after zoledronic acid administration. Moreover, in patients who experienced fever, the TNF-alpha and IL-6 increases were higher than in patients without fever. No statistically significant differences in IFN-gamma were identified at different time points in patients with and without fever. Our results show that zoledronic acid induces transient TNF-alpha and IL-6 increases and that these increases are higher in patients who have developed fever, suggesting that these cytokines could be responsible for fever pathogenesis. The sharp reduction in serum calcium levels observed in patients with fever may be related to zoledronic acid pharmacokinetic modifications." @default.
• W2081478283 created "2016-06-24" @default.
• W2081478283 creator A5006410643 @default.
• W2081478283 creator A5017327209 @default.
• W2081478283 creator A5025063054 @default.
• W2081478283 creator A5027541951 @default.
• W2081478283 creator A5048563798 @default.
• W2081478283 creator A5059367989 @default.
• W2081478283 creator A5060064110 @default.
• W2081478283 creator A5069634427 @default.
• W2081478283 creator A5075763206 @default.
• W2081478283 creator A5081470600 @default.
• W2081478283 date "2003-11-01" @default.
• W2081478283 modified "2023-10-18" @default.
• W2081478283 title "Fever After Zoledronic Acid Administration Is Due to Increase in TNF-<i>α</i>and IL-6" @default.
• W2081478283 cites W1821840597 @default.
• W2081478283 cites W1951349736 @default.
• W2081478283 cites W1978701783 @default.
• W2081478283 cites W1982145456 @default.
• W2081478283 cites W1996593783 @default.
• W2081478283 cites W1996898338 @default.
• W2081478283 cites W2052659304 @default.
• W2081478283 cites W2063084132 @default.
• W2081478283 cites W2067420120 @default.
• W2081478283 cites W2074890088 @default.
• W2081478283 cites W2076111367 @default.
• W2081478283 cites W2076769374 @default.
• W2081478283 cites W2116305785 @default.
• W2081478283 cites W2125976746 @default.
• W2081478283 cites W2149707203 @default.
• W2081478283 cites W2158226610 @default.
• W2081478283 cites W2169132546 @default.
• W2081478283 cites W2316096113 @default.
• W2081478283 cites W2325302070 @default.
• W2081478283 cites W2607028219 @default.
• W2081478283 cites W4206711942 @default.
• W2081478283 cites W4241215726 @default.
• W2081478283 cites W4241837822 @default.
• W2081478283 cites W4252639760 @default.
• W2081478283 cites W60551495 @default.
• W2081478283 doi "https://doi.org/10.1089/107999003322558782" @default.
• W2081478283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14651779" @default.
• W2081478283 hasPublicationYear "2003" @default.
• W2081478283 type Work @default.
• W2081478283 sameAs 2081478283 @default.
• W2081478283 citedByCount "126" @default.
• W2081478283 countsByYear W20814782832012 @default.
• W2081478283 countsByYear W20814782832013 @default.
• W2081478283 countsByYear W20814782832014 @default.
• W2081478283 countsByYear W20814782832015 @default.
• W2081478283 countsByYear W20814782832016 @default.
• W2081478283 countsByYear W20814782832017 @default.
• W2081478283 countsByYear W20814782832018 @default.
• W2081478283 countsByYear W20814782832019 @default.
• W2081478283 countsByYear W20814782832020 @default.
• W2081478283 countsByYear W20814782832021 @default.
• W2081478283 countsByYear W20814782832022 @default.
• W2081478283 countsByYear W20814782832023 @default.
• W2081478283 crossrefType "journal-article" @default.
• W2081478283 hasAuthorship W2081478283A5006410643 @default.
• W2081478283 hasAuthorship W2081478283A5017327209 @default.
• W2081478283 hasAuthorship W2081478283A5025063054 @default.
• W2081478283 hasAuthorship W2081478283A5027541951 @default.
• W2081478283 hasAuthorship W2081478283A5048563798 @default.
• W2081478283 hasAuthorship W2081478283A5059367989 @default.
• W2081478283 hasAuthorship W2081478283A5060064110 @default.
• W2081478283 hasAuthorship W2081478283A5069634427 @default.
• W2081478283 hasAuthorship W2081478283A5075763206 @default.
• W2081478283 hasAuthorship W2081478283A5081470600 @default.
• W2081478283 hasConcept C126322002 @default.
• W2081478283 hasConcept C126894567 @default.
• W2081478283 hasConcept C134018914 @default.
• W2081478283 hasConcept C17991360 @default.
• W2081478283 hasConcept C197934379 @default.
• W2081478283 hasConcept C2776326535 @default.
• W2081478283 hasConcept C2776541429 @default.
• W2081478283 hasConcept C2777251235 @default.
• W2081478283 hasConcept C2778024521 @default.
• W2081478283 hasConcept C2778690821 @default.
• W2081478283 hasConcept C2779306644 @default.
• W2081478283 hasConcept C2780942790 @default.
• W2081478283 hasConcept C71924100 @default.
• W2081478283 hasConcept C90924648 @default.
• W2081478283 hasConceptScore W2081478283C126322002 @default.
• W2081478283 hasConceptScore W2081478283C126894567 @default.
• W2081478283 hasConceptScore W2081478283C134018914 @default.
• W2081478283 hasConceptScore W2081478283C17991360 @default.
• W2081478283 hasConceptScore W2081478283C197934379 @default.
• W2081478283 hasConceptScore W2081478283C2776326535 @default.
• W2081478283 hasConceptScore W2081478283C2776541429 @default.
• W2081478283 hasConceptScore W2081478283C2777251235 @default.
• W2081478283 hasConceptScore W2081478283C2778024521 @default.
• W2081478283 hasConceptScore W2081478283C2778690821 @default.
• W2081478283 hasConceptScore W2081478283C2779306644 @default.
• W2081478283 hasConceptScore W2081478283C2780942790 @default.
• W2081478283 hasConceptScore W2081478283C71924100 @default.
• W2081478283 hasConceptScore W2081478283C90924648 @default.
• W2081478283 hasIssue "11" @default.

• next